Loading…
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy
HIV-1-infected individuals with plasma RNA100,000 copies/ml and on-therapy RNA levels below detection limits of commercial assays for ≥ 6 months. Of 103 patients eligible for analysis, the median age was 46 years and the median duration of viral suppression was 4.8 years. 62% had detectable viraemia...
Saved in:
Published in: | Antiviral therapy 2013, Vol.18 (1), p.39-43 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | HIV-1-infected individuals with plasma RNA100,000 copies/ml and on-therapy RNA levels below detection limits of commercial assays for ≥ 6 months.
Of 103 patients eligible for analysis, the median age was 46 years and the median duration of viral suppression was 4.8 years. 62% had detectable viraemia (>0.2 copies/ml) by SCA (median 0.2 copies/ml, IQR 2 years (median 2.3 versus 0.2 copies/ml; P=0.016).
Among HIV-1-infected patients with pre-ART HIV-1 RNA>100,000 copies/ml, residual viraemia was detectable in the majority (62%) despite many years of suppressive ART. Higher level viraemia was associated with older age and |
---|---|
ISSN: | 1359-6535 2040-2058 |
DOI: | 10.3851/IMP2323 |